Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatocellular carcinoma presenting with intractable diarrhea. A radiologic-pathologic correlation.

E Steiner, P Velt, O Gutierrez

    Archives of Surgery (Chicago, Ill. : 1960)
    |July 1, 1986
    PubMed
    Summary

    A 44-year-old woman with hepatocellular carcinoma experienced intractable diarrhea. Angiography and surgery were used to evaluate and remove the tumor. Tumor cells were found to contain vasoactive intestinal polypeptide, gastrin, and prostaglandin-like immunoactivity. After tumor ablation, the diarrhea resolved completely. This is the first report linking hepatocellular carcinoma with such symptoms. The study suggests that tumor-derived peptides may cause gastrointestinal dysfunction. The findings provide a radiologic-pathologic correlation in a rare clinical scenario.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Harvester ant colonies differ in collective behavioural plasticity to regulate water loss.

    Royal Society open science·2023
    Same author

    Corrigendum to 'Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study': [ESMO Open Volume 7, Issue 2, April 2022, 100466].

    ESMO open·2022
    Same author

    ESTRO-ACROP guideline on surface guided radiation therapy.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2022
    Same author

    Surface guided radiation therapy: An international survey on current clinical practice.

    Technical innovations & patient support in radiation oncology·2022
    Same author

    Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study.

    ESMO open·2022
    Same author

    A reply to "Relevant factors in the eutrophication of the Uruguay River and the Río Negro".

    The Science of the total environment·2021

    Area of Science:

    • Gastrointestinal tumor pathology
    • Hepatobiliary radiology
    • Neuroendocrine tumor diagnostics

    Background:

    It was already known that certain liver tumors can produce hormones or peptides that affect distant organs. However, no prior work had resolved how hepatocellular carcinoma might specifically cause gastrointestinal symptoms like diarrhea. Prior research has shown that vasoactive intestinal polypeptide and gastrin can influence bowel function, but their role in liver tumors remained unclear. This gap motivated a closer examination of tumor composition in cases with unexplained diarrhea. No prior work had resolved whether tumor-derived peptides could directly cause bowel symptoms. That uncertainty drove the need to correlate radiological findings with pathological analysis. This gap motivated the investigation into whether tumor ablation could reverse the diarrhea. The study aimed to bridge the gap between clinical presentation and tumor biology.

    Purpose Of The Study:

    The aim was to determine if a liver tumor could produce peptides that cause intractable diarrhea. The specific problem was to identify the mechanism behind unexplained watery diarrhea in a patient with hepatocellular carcinoma. The motivation was to understand if tumor-derived peptides could act as paracrine or endocrine signals. This gap motivated the use of both radiological and pathological methods. The study sought to confirm whether tumor ablation could reverse the diarrhea. This gap motivated the collection of tumor samples for immunohistochemical analysis. The study aimed to provide a radiologic-pathologic correlation in a rare clinical scenario. The goal was to document a novel association between tumor peptides and bowel dysfunction.

    Keywords:
    Hepatocellular carcinomaVasoactive intestinal polypeptideIntractable diarrheaLiver tumor pathology

    Frequently Asked Questions

    The authors propose that tumor-derived peptides, including vasoactive intestinal polypeptide and gastrin, may act on the gastrointestinal tract to cause diarrhea.

    Vasoactive intestinal polypeptide, gastrin, and prostaglandin-like immunoactivity were found in the tumor cells.

    Surgical ablation resulted in complete resolution of the diarrhea, suggesting a direct link between the tumor and the symptoms.

    Immunohistochemistry confirmed the presence of vasoactive intestinal polypeptide and gastrin in the tumor tissue.

    Related Experiment Videos

    Main Methods:

    The patient underwent angiography to evaluate the tumor's vascular supply. Tumor tissue was collected for immunohistochemical analysis. Vasoactive intestinal polypeptide was detected using specific antibodies. Gastrin and prostaglandin-like immunoactivity were also identified. The tumor was surgically removed to assess symptom resolution. Radiologic imaging was compared with pathological findings. The presence of peptides was confirmed using standard immunohistochemical techniques. The study combined clinical, radiological, and pathological approaches.

    Main Results:

    Surgical ablation of the tumor led to complete resolution of the diarrhea. Immunohistochemistry showed vasoactive intestinal polypeptide in tumor cells. Gastrin was also detected within the tumor tissue. Prostaglandin-like immunoactivity was present in the tumor. The tumor's peptide content suggested a paracrine or endocrine mechanism. No prior work had resolved this specific association between hepatocellular carcinoma and diarrhea. The study confirmed a direct link between tumor peptides and bowel symptoms. The findings suggest that tumor-derived peptides may cause gastrointestinal dysfunction.

    Conclusions:

    The authors propose that hepatocellular carcinoma can produce peptides that cause diarrhea. Their findings suggest a novel paracrine or endocrine mechanism. The study confirms that tumor ablation can reverse the symptoms. The presence of vasoactive intestinal polypeptide was a key finding. Gastrin and prostaglandin-like immunoactivity were also significant. The authors propose that these peptides may act on the gastrointestinal tract. The study provides a radiologic-pathologic correlation in a rare case. The findings suggest that tumor-derived peptides may contribute to bowel dysfunction.

    Vasoactive intestinal polypeptide may act as a paracrine or endocrine signal to influence bowel function.

    The authors propose that tumor ablation may be an effective treatment for diarrhea caused by tumor-derived peptides.